Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.

Abstract:

:Non-insulin-dependent diabetic (NIDDM) patients were studied during a modified euglycaemic state when fasting hyperglycaemia was normalized by a prior (-210 to -150 min)--and later withdrawn (-150-0 min)--intravenous insulin infusion. Glucose metabolism was assessed in NIDDM patients (n = 10) and matched control subjects (n = 10) using tritiated glucose turnover rates, indirect calorimetry and skeletal muscle glycogen synthase activity determinations. Total and non-oxidative exogenous glycolytic flux rates were measured using appearance rates of tritiated water. A + 180 min euglycaemic hyperinsulinaemic (40 mU.m-2.min-1) clamp was performed to determine the insulin responsiveness of the various metabolic pathways. Plasma glucose concentration increased spontaneously during baseline measurements in the NIDDM patients (-120 to 0 min: 4.8 +/- 0.3 to 7.0 +/- 0.3 mmol/l; p < 0.01), and was primarily due to an elevated rate of hepatic glucose production (3.16 +/- 0.13 vs 2.51 +/- 0.16 mg.kg FFM-1.min-1; p < 0.01). In the NIDDM subjects baseline glucose oxidation was decreased (0.92 +/- 0.17 vs 1.33 +/- 0.14 mg.kg FFM-1.min-1; p < 0.01) in the presence of a normal rate of total exogenous glycolytic flux and skeletal muscle glycogen synthase activity. The simultaneous finding of an increased lipid oxidation rate (1.95 +/- 0.13 vs 1.61 +/- 0.07 mg.kg FFM-1.min-1; p = 0.05) and increased plasma lactate concentrations (0.86 +/- 0.05 vs 0.66 +/- 0.03 mmol/l; p = 0.01) are consistent with a role for both the glucose-fatty acid cycle and the Cori cycle in the maintenance and development of fasting hyperglycaemia in NIDDM during decompensation. Insulin resistance was demonstrated during the hyperinsulinaemic clamp in the NIDDM patients with a decrease in the major peripheral pathways of intracellular glucose metabolism (oxidation, storage and muscle glycogen synthase activity), but not in the pathway of non-oxidative glycolytic flux which was not completely suppressed during insulin infusion in the NIDDM patients (0.55 +/- 0.15 mg.kg FFM-1.min-1; p < 0.05 vs 0; control subjects: 0.17 +/- 0.29; NS vs 0). Thus, these data also indicate that the defect(s) of peripheral (skeletal muscle) glucose processing in NIDDM goes beyond the site of glucose transport across the cell membrane.

journal_name

Diabetologia

journal_title

Diabetologia

authors

Vaag A,Alford F,Henriksen FL,Christopher M,Beck-Nielsen H

doi

10.1007/BF00400638

subject

Has Abstract

pub_date

1995-03-01 00:00:00

pages

326-36

issue

3

eissn

0012-186X

issn

1432-0428

journal_volume

38

pub_type

杂志文章
  • Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor.

    abstract::Downregulation of insulin receptor tyrosine kinase (IRK) activity yields to impaired insulin signalling and contributes to the pathogenesis of cellular insulin resistance. Activation of protein kinase C (PKC) by different agents is associated with an inhibition of IRK activity in various cell types. There is evidence ...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250050761

    authors: Bossenmaier B,Mosthaf L,Mischak H,Ullrich A,Häring HU

    更新日期:1997-07-01 00:00:00

  • Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance.

    abstract:AIMS/HYPOTHESIS:Mitochondria-associated endoplasmic reticulum membranes (MAMs) are regions of the endoplasmic reticulum (ER) tethered to mitochondria and controlling calcium (Ca(2+)) transfer between both organelles through the complex formed between the voltage-dependent anion channel, glucose-regulated protein 75 and...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-015-3829-8

    authors: Rieusset J,Fauconnier J,Paillard M,Belaidi E,Tubbs E,Chauvin MA,Durand A,Bravard A,Teixeira G,Bartosch B,Michelet M,Theurey P,Vial G,Demion M,Blond E,Zoulim F,Gomez L,Vidal H,Lacampagne A,Ovize M

    更新日期:2016-03-01 00:00:00

  • Inhibition of matrix-induced bone differentiation by advanced glycation end-products in rats.

    abstract::Glycation of long-lived proteins is an inevitable consequence of aging that is accelerated in patients with diabetes mellitus. Treatment of demineralized bone matrix particles from 35-week-old normal Long-Evans rats with glycoaldehyde, a precursor of advanced glycation end-products, was used to assess the effects of b...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00400353

    authors: Fong Y,Edelstein D,Wang EA,Brownlee M

    更新日期:1993-09-01 00:00:00

  • Association analysis of the IGF1 gene with childhood growth, IGF-1 concentrations and type 1 diabetes.

    abstract:AIMS/HYPOTHESIS:Insulin-like growth factor-1 is a major childhood growth factor and promotes pancreatic islet cell survival and growth in vitro. We hypothesised that genetic variation in IGF1 might be associated with childhood growth, glucose metabolism and type 1 diabetes risk. We therefore examined the association be...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-008-0970-7

    authors: Vella A,Bouatia-Naji N,Heude B,Cooper JD,Lowe CE,Petry C,Ring SM,Dunger DB,Todd JA,Ong KK

    更新日期:2008-05-01 00:00:00

  • Cellular characterisation of the GCKR P446L variant associated with type 2 diabetes risk.

    abstract:AIMS/HYPOTHESIS:Translation of genetic association signals into molecular mechanisms for diabetes has been slow. The glucokinase regulatory protein (GKRP; gene symbol GCKR) P446L variant, associated with inverse modulation of glucose- and lipid-related traits, has been shown to alter the kinetics of glucokinase (GCK) i...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-011-2348-5

    authors: Rees MG,Wincovitch S,Schultz J,Waterstradt R,Beer NL,Baltrusch S,Collins FS,Gloyn AL

    更新日期:2012-01-01 00:00:00

  • Engineered cell lines for insulin replacement in diabetes: current status and future prospects.

    abstract::The recently completed diabetes complications and control trial has highlighted the need for improvement of insulin delivery systems for treatment of insulin-dependent diabetes mellitus. Despite steady improvement in methods for islet and whole pancreas transplantation over the past three decades, the broad-scale appl...

    journal_title:Diabetologia

    pub_type: 杂志文章,评审

    doi:10.1007/s001250051398

    authors: Newgard CB,Clark S,BeltrandelRio H,Hohmeier HE,Quaade C,Normington K

    更新日期:1997-07-01 00:00:00

  • Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats.

    abstract:AIMS/HYPOTHESIS:Leptin resistance is generally considered a consequence of obesity. We postulated that leptin resistance is associated with diminished hypothalamic leptin signalling capacity and that leptin resistance is causal to obesity. We assessed maximal leptin-mediated binding of the transcription factor signal t...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-005-1763-x

    authors: Scarpace PJ,Matheny M,Tümer N,Cheng KY,Zhang Y

    更新日期:2005-06-01 00:00:00

  • Meta-analysis of the effects of n-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes.

    abstract:AIMS/HYPOTHESIS:To determine the effects of marine-derived n-3 polyunsaturated fatty acids (PUFA) on established and emerging lipid and lipoprotein cardiovascular risk markers in patients with type 2 diabetes. MATERIALS AND METHODS:We performed a systematic review and meta-analysis of randomised controlled trials comp...

    journal_title:Diabetologia

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s00125-007-0695-z

    authors: Hartweg J,Farmer AJ,Perera R,Holman RR,Neil HA

    更新日期:2007-08-01 00:00:00

  • Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice.

    abstract:AIMS/HYPOTHESIS:Clinical trials are in progress to test thiazolidinediones in neurodegenerative diseases such as Alzheimer's disease that involve deficiencies in brain glucose metabolism. While thiazolidinediones enhance glucose uptake in non-cerebral tissues, their impact on brain energy metabolism has not been invest...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-006-0326-0

    authors: Galea E,Feinstein DL,Lacombe P

    更新日期:2006-09-01 00:00:00

  • Depression as a risk factor for dementia in older people with type 2 diabetes and the mediating effect of inflammation.

    abstract:AIMS/HYPOTHESIS:We aimed to determine the association of depression with dementia risk in people with type 2 diabetes, and to explore the possible mediating role of inflammation in this relationship. METHODS:The Edinburgh Type 2 Diabetes Study is a prospective cohort of 1066 men and women with type 2 diabetes aged 60-...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-020-05301-6

    authors: Carr AL,Sluiman AJ,Grecian SM,Forster R,McLachlan S,Strachan MWJ,Price JF

    更新日期:2021-02-01 00:00:00

  • The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients.

    abstract:AIMS/HYPOTHESIS:Pancreatic beta cells have highly developed endoplasmic reticulum (ER) due to their role in insulin secretion. Since ER stress has been associated with beta cell dysfunction, we studied several features of beta cell ER in human type 2 diabetes. METHODS:Pancreatic samples and/or isolated islets from non...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-007-0816-8

    authors: Marchetti P,Bugliani M,Lupi R,Marselli L,Masini M,Boggi U,Filipponi F,Weir GC,Eizirik DL,Cnop M

    更新日期:2007-12-01 00:00:00

  • Raised serum apolipoprotein (a) in active diabetic retinopathy.

    abstract::Progressive capillary occlusion often leads to severe retinopathy within 15-20 years of the onset of Type 1 (insulin-dependent) diabetes mellitus. Lipoprotein(a), a complex formed by apolipoprotein(a), apo B-100 and lipids, is considered an independent, genetically determined, predictor of cardiovascular disease. It m...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00399100

    authors: Maioli M,Tonolo G,Pacifico A,Ciccarese M,Brizzi P,Kohner EM,Porta M

    更新日期:1993-01-01 00:00:00

  • Spatial distribution of early red lesions is a risk factor for development of vision-threatening diabetic retinopathy.

    abstract:AIMS/HYPOTHESIS:Diabetic retinopathy is characterised by morphological lesions related to disturbances in retinal blood flow. It has previously been shown that the early development of retinal lesions temporal to the fovea may predict the development of treatment-requiring diabetic maculopathy. The aim of this study wa...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-017-4424-y

    authors: Ometto G,Assheton P,Calivá F,Chudzik P,Al-Diri B,Hunter A,Bek T

    更新日期:2017-12-01 00:00:00

  • The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS).

    abstract:AIMS/HYPOTHESIS:Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activato...

    journal_title:Diabetologia

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00125-012-2741-8

    authors: Lee CC,Lorenzo C,Haffner SM,Wagenknecht LE,Festa A,Goodarzi MO,Stefanovski D,Olson NC,Norris JM,Rewers MJ,Hanley AJ

    更新日期:2013-01-01 00:00:00

  • The G972R variant of the insulin receptor substrate-1 (IRS-1) gene, body fat distribution and insulin-resistance.

    abstract:AIMS/HYPOTHESIS:Insulin resistance is recognised as the core factor in the pathogenesis of Type II (non-insulin-dependent) diabetes mellitus, hypertension and atherosclerosis. Several studies indicate the possible role of mutations of the insulin receptor substrate-1 (IRS-1) gene in the pathogenesis of insulin-resistan...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s001250051628

    authors: Baroni MG,Arca M,Sentinelli F,Buzzetti R,Capici F,Lovari S,Vitale M,Romeo S,Di Mario U

    更新日期:2001-03-01 00:00:00

  • Type 1 and type 2 diabetes after gestational diabetes: a 23 year cohort study.

    abstract:AIMS/HYPOTHESIS:The aim of this work was to examine the progression to type 1 and type 2 diabetes after gestational diabetes mellitus (GDM) in a 23 year follow-up study. METHODS:We carried out a cohort study of 391 women with GDM diagnosed by an OGTT or the use of insulin treatment during pregnancy, and 391 age- and p...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-020-05215-3

    authors: Auvinen AM,Luiro K,Jokelainen J,Järvelä I,Knip M,Auvinen J,Tapanainen JS

    更新日期:2020-10-01 00:00:00

  • Towards a systematic nationwide screening strategy for MODY.

    abstract::MODY is an early-onset monogenic form of diabetes. Correctly identifying MODY is of considerable importance as diagnosing the specific genetic subtype can inform the optimal treatment, with many patients being able to discontinue unnecessary insulin treatment. Diagnostic molecular genetic testing to confirm MODY is ex...

    journal_title:Diabetologia

    pub_type: 评论,社论

    doi:10.1007/s00125-017-4213-7

    authors: Shields B,Colclough K

    更新日期:2017-04-01 00:00:00

  • Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity.

    abstract:AIMS/HYPOTHESIS:This study was aimed at the elucidation of the pathogenesis of glucotoxicity, i.e. the mechanism whereby hyperglycaemia damages pancreatic beta cells. The identification of pathways in the process may help identify targets for beta cell-protective therapy. Carbohydrate response element-binding protein (...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-012-2506-4

    authors: Poungvarin N,Lee JK,Yechoor VK,Li MV,Assavapokee T,Suksaranjit P,Thepsongwajja JJ,Saha PK,Oka K,Chan L

    更新日期:2012-06-01 00:00:00

  • Inability to stimulate skeletal muscle or whole body protein synthesis in type 1 (insulin-dependent) diabetic patients by insulin-plus-glucose during amino acid infusion: studies of incorporation and turnover of tracer L-[1-13C]leucine.

    abstract::Despite its anabolic effects on protein balance, acute administration of insulin has been reported to have no effect on skeletal muscle or whole body protein synthesis in man. However, insulin also reduces plasma and intramuscular amino acid availability, which may limit protein synthesis. We have therefore measured t...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00586460

    authors: Bennet WM,Connacher AA,Smith K,Jung RT,Rennie MJ

    更新日期:1990-01-01 00:00:00

  • Detection of IgE insulin antibody with radioallergosorbent test.

    abstract::An in vitro method for detecting IgE insulin antibody using the principle of the radioallergosorbent test (RAST) is described. In six patients with insulin allergy, the RAST values were higher than in normal persons or insulin-treated diabetics without insulin-allergy. No differences were observed between normal perso...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00429705

    authors: Nakagawa S,Saito N,Nakayama H,Sasaki T,Watanabe T,Aoki S

    更新日期:1978-01-14 00:00:00

  • Heterogeneity of the haemoglobin-A1c-band in isoelectric focussing.

    abstract::A double HbA1c-band was demonstrated in isoelectric focussing of blood from diabetics with a fasting blood glucose above 11 mmol/l. The same band-doubling was also demonstrated after incubation of erythrocytes in glucose/saline solutions. This finding may reflect the presence of the initial condensation product betwee...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00281827

    authors: Welinder BS,Svendsen PA

    更新日期:1980-11-01 00:00:00

  • Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited.

    abstract::Significant progress has been made in recent years in the characterisation of the signal pathways of beta cell dysfunction and death in the pathogenesis of type 2 diabetes. Glucolipotoxicity acts as an exogenous factor whereas oxidative stress and endoplasmic reticulum stress may result from the processes of signal re...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-010-1839-0

    authors: Rustenbeck I,Baltrusch S,Tiedge M

    更新日期:2010-10-01 00:00:00

  • On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis.

    abstract::For the normalisation of blood glucose levels in diabetic patients by feedback controlled insulin delivery, a self-manageable and reliable method for continuous glucose estimation is still not available. By combining a commercially available needle type dialysis probe (molecular cutoff 20,000 Da) with a sensitive gluc...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF02221686

    authors: Meyerhoff C,Bischof F,Sternberg F,Zier H,Pfeiffer EF

    更新日期:1992-11-01 00:00:00

  • Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism.

    abstract:AIMS/HYPOTHESIS:The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-011-2289-z

    authors: Norton L,Fourcaudot M,Abdul-Ghani MA,Winnier D,Mehta FF,Jenkinson CP,Defronzo RA

    更新日期:2011-12-01 00:00:00

  • Type I (insulin dependent) diabetes mellitus. Is there strong evidence for a non-HLA linked gene?

    abstract::A recent investigation of families containing two and three consecutive generations affected with Type I (insulin dependent) diabetes mellitus has led to speculation that there is a second susceptibility gene, not linked to the major histocompatibility complex. These families differ in important respects from families...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00252759

    authors: Suarez BK,Van Eerdewegh P

    更新日期:1981-05-01 00:00:00

  • The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.

    abstract:AIMS/HYPOTHESIS:Glucagon-like peptide-1 (GLP-1), a polypeptide hormone secreted by the l-cells in the gastrointestinal tract, has shown promising effects as a new treatment modality for patients with Type II (non-insulin-dependent) diabetes mellitus. However, the pharmacokinetic profile of native GLP-1 with a rapid eli...

    journal_title:Diabetologia

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1007/s00125-001-0719-z

    authors: Agersø H,Jensen LB,Elbrønd B,Rolan P,Zdravkovic M

    更新日期:2002-02-01 00:00:00

  • Expression of glycogen synthase and phosphofructokinase in muscle from type 1 (insulin-dependent) diabetic patients before and after intensive insulin treatment.

    abstract::The aim of the present study was to determine whether short-term appropriate insulinization of Type 1 (insulin-dependent) diabetic patients in long-term poor glycaemic control (HbA1C > 9.5%) was associated with an adaptive regulation of the activity and gene expression of key proteins in muscle glycogen storage and gl...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/BF00428782

    authors: Vestergaard H,Andersen PH,Lund S,Vedel P,Pedersen O

    更新日期:1994-01-01 00:00:00

  • Advances and prospects in glucose assay technology.

    abstract::The evolution of glucose assay methods has been central to the development of present therapies for diabetes mellitus. However, new blood glucose assay capabilities, such as convenient and truly continuous monitoring, are now needed to foster a new era of close blood glucose control. The principles and present status ...

    journal_title:Diabetologia

    pub_type: 杂志文章,评审

    doi:10.1007/s001250051418

    authors: Gough DA,Armour JC,Baker DA

    更新日期:1997-07-01 00:00:00

  • Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.

    abstract:AIMS/HYPOTHESIS:Measurement of plasma apolipoprotein (Apo) B may improve prediction of cardiovascular risk, as it provides a measure of the total number of atherogenic particles. The aim of this population-based study was to compare the association of non-HDL-cholesterol, ApoB and the ApoB:ApoA-I ratio with cardiovascu...

    journal_title:Diabetologia

    pub_type: 杂志文章,多中心研究

    doi:10.1007/s00125-006-0195-6

    authors: Bruno G,Merletti F,Biggeri A,Bargero G,Prina-Cerai S,Pagano G,Cavallo-Perin P

    更新日期:2006-05-01 00:00:00

  • Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: impli

    abstract:AIMS/HYPOTHESIS:We investigated whether screening for insulinoma-associated protein (IA-2) beta (IA-2beta) autoantibodies (IA-2betaA) and zinc transporter-8 (ZnT8) autoantibodies (ZnT8A) improves identification of first-degree relatives of type 1 diabetic patients with a high 5-year disease risk, which to date has been...

    journal_title:Diabetologia

    pub_type: 杂志文章

    doi:10.1007/s00125-009-1618-y

    authors: De Grijse J,Asanghanwa M,Nouthe B,Albrecher N,Goubert P,Vermeulen I,Van Der Meeren S,Decochez K,Weets I,Keymeulen B,Lampasona V,Wenzlau J,Hutton JC,Pipeleers D,Gorus FK,Belgian Diabetes Registry.

    更新日期:2010-03-01 00:00:00